Journal of experimental & clinical cancer research : CR
Novel APLNR antagonist candesartan induces tumor vascular normalization through ROS/cGAS/STING axis and augmented sunitinib response in breast cancer.
Chenyu Liang, Mingzhu Wang, Tianxin Li, Yongtao Duan, Chuanjun Song, Yongfang Yao
Published: 202510.1186/s13046-025-03584-4
No abstract available for this study.